New poll shows New York voters support global health research but unsure where it is conducted

Global Health R&D Forum convenes global health advocates, researchers and industry leaders

2012-04-10

(Press-News.org) WASHINGTON—April 9, 2012— New York voters recognize the importance of global health research and are concerned about the United States' ability to compete globally, according to a new poll commissioned by Research!America, yet an overwhelming majority (93%) of those polled don't know where global health research is conducted in their own state.

The majority of New Yorkers (64%) think that New York residents should be concerned about global health and an additional 63% believe that spending money on global health is important to their state's economy. However, poll results indicate a lack of awareness about where this research takes place.

"New Yorkers value global health research as a means of protecting us all from diseases that invariably cross borders, and as an important component of the state's thriving biosciences sector," said Research!America Chair and former Congressman John Edward Porter. "As home to highly successful pharmaceutical companies and innovative global health product development partnerships, New York is in a unique position to increase investment in global health research and help maintain our world leadership in research and innovation."

Results of the New York state poll will be announced today at the public forum, Global Health Research and Development in New York: Fueling Innovation and Saving Lives to be held at the New York Academy of Sciences in New York. U.S. Rep. Nita M. Lowey (D-NY-18th District) will provide opening remarks. A new fact sheet notes that New York City alone has the largest bioscience workforce and the second largest life sciences workforce of any U.S. city, employing a combined 80,000 people at an average wage of $75,700.

Global health research facilitates the diagnosis, prevention, treatment and cure of diseases such as malaria, HIV/AIDS and tuberculosis (TB) that disproportionately affect developing countries. "Innovative research and development holds the potential to save lives and improve health at home and abroad," said Congresswoman Nita Lowey. "Federal support for R&D plays a critical role in creating jobs and growing the economy right here in New York. I am thrilled to stand with Research!America in support of one of New York's most important and beneficial industries."

New York's research and development commitment is exemplified by the new applied sciences campus championed by Governor Bloomberg and developed through a partnership between Cornell University and Technion. The new campus is expected to generate nearly 600 spin-off companies, 38,000 permanent jobs, $23 billion in economic activity and $1.4 billion in tax revenue.

"Research and development, whether focused on global infectious diseases or chronic illnesses prevalent in the United States, brings abundant health and economic benefits to New York," said Mary Woolley, president and CEO of Research!America. In the last 10-15 years, over 20 New York organizations with a stake in global health R&D have either been created or have expanded their mandate and added locations, centers or projects. "It's surprising that New Yorkers aren't aware of the many fine institutions, businesses, and organizations accomplishing this work; New Yorkers should be proud of what they and their state are accomplishing," Woolley added. In addition to being home to seven of the top 50 American research universities and two of the top 25 medical research universities, New York houses some of the world's most innovative public-private partnerships working to develop drugs and vaccines for global health, including the Drugs for Neglected Diseases Initiative North America (DNDi), The Global Alliance for TB Drug Development (TB Alliance) and the International AIDS Vaccine Initiative (IAVI). DNDi has 13 drugs in the pipeline and the TB Alliance just announced a new drug trial that may reduce costs by 90%, treatment time by 80%, and provide greater protection against drug resistant TB strains. IAVI's Brooklyn lab is contributing to the search and development of promising AIDS vaccine breakthroughs.

Additional poll findings show:

Most New Yorkers (86%) are concerned about drug resistance as well as preventing it (85%) around the world; 53% say global health research creates jobs; 72% say it is important for New York to offer tax or other incentives for companies to invest in research to improve health globally; 69% say that Americans will be better off if the U.S. government invests in global health research; and 74% say the U.S. is in danger of losing its global competitive edge.

###To view results of the poll, fact sheet, and to learn more about global health R&D efforts in New York, please visit: http://www.researchamerica.org/gh_newyork

About the poll: The New York Global Health poll was conducted online in January 2012 by JZ Analytics for Research!America. A sample size of 800 adult residents of New York participated in the poll, offering a theoretical sampling error of between +/– 3.5% and 3.9%.

About Us: Research!America is the nation's largest nonprofit public education and advocacy alliance working to make research to improve health a higher national priority. Visit www.researchamerica.org.

ELSE PRESS RELEASES FROM THIS DATE:

'Nanobubbles' plus chemotherapy equals single-cell cancer targeting

2012-04-10

HOUSTON -- (April 9, 2012) -- Using light-harvesting nanoparticles to convert laser energy into "plasmonic nanobubbles," researchers at Rice University, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine (BCM) are developing new methods to inject drugs and genetic payloads directly into cancer cells. In tests on drug-resistant cancer cells, the researchers found that delivering chemotherapy drugs with nanobubbles was up to 30 times more deadly to cancer cells than traditional drug treatment and required less than one-tenth the clinical dose. "We ...

Researchers identify genes that may help in ovarian cancer diagnosis and prognosis

2012-04-10

Philadelphia, PA, April 9, 2012 – Scientists from Duke University Medical Center have determined that genes acting as molecular "on/off" switches can define clinically relevant molecular subtypes of ovarian cancer, providing ideal potential targets for use in clinical prognostic and diagnostic testing. These bimodal genes can define tumor subtypes that have different overall prognoses and respond to different therapeutic regimens. The researchers' results are published in the May issue of The Journal of Molecular Diagnostics. "We identified a very small set of genes ...

A better tool to diagnose tuberculosis

2012-04-10

Up to 30% of the world's population is infected with Tuberculosis (TB), but in many areas of the world, TB diagnosis still relies on insensitive, poorly standardized, and time-consuming methods. A new diagnostic tool, endorsed by the World Health Organization (WHO), may change that. Dr. Thomas Bodmer shows how it's done in the Journal of Visualized Experiments (JoVE). Currently, TB is diagnosed through either a skin test, which produces a small bump on the patient's arm when administered and needs to be checked after 72 hours, and through smear microscopy, a method that ...

WirelessTimeClock.com Launches Redesigned Site

2012-04-10

WirelessTimeClock.com, a trusted source for web-based time clocks, has re-launched its website (http://www.wirelesstimeclock.com) with a more intuitive and streamlined design, promising a more enriching experience for businesses searching for reliable employee time clocks and time and attendance management solutions. "Our customers have been asking for a more intuitive, resourceful site," says Scott Tobin, owner of WirelessTimeClock.com. "We wanted to make sure they could find exactly the clocks and monthly plans that would fit their business needs." With ...

High-resolution atomic imaging of specimens in liquid by TEM using graphene liquid cell

2012-04-10

Daejeon, the Republic of Korea, April 9, 2012—The Korea Advanced Institute of Science and Technology (KAIST) announced that a research team from the Department of Materials Science and Engineering has developed a technology that enables scientists and engineers to observe processes occurring in liquid media on the smallest possible scale which is less than a nanometer. Professor Jeong Yong Lee and Researcher Jong Min Yuk, in collaboration with Professor Paul Alivisatos's and Professor Alex Zettl's groups at the University of California, Berkeley, succeeded in making ...

Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines

2012-04-10

Combining two strategies designed to improve the results of cancer treatment – antiangiogenesis drugs and nanomedicines – may only be successful if the smallest nanomedicines are used. A new study from Massachusetts General Hospital (MGH) researchers, appearing in Nature Nanotechnology, finds that normalizing blood vessels within tumors, which improves the delivery of standard chemotherapy drugs, can block the delivery of larger nanotherapy molecules. "We found that vascular normalization only increases the delivery of the smallest nanomedicines to cancer cells," says ...

SDO and STEREO spot something new on the sun

2012-04-10

One day in the fall of 2011, Neil Sheeley, a solar scientist at the Naval Research Laboratory in Washington, D.C., did what he always does – look through the daily images of the sun from NASA's Solar Dynamics Observatory (SDO). But on this day he saw something he'd never noticed before: a pattern of cells with bright centers and dark boundaries occurring in the sun's atmosphere, the corona. These cells looked somewhat like a cell pattern that occurs on the sun's surface -- similar to the bubbles that rise to the top of boiling water -- but it was a surprise to find this ...

Atlanta Hardwood Flooring Can Be "Baby-Proof" If Done By FlooringAtlantaNow.com

2012-04-10

It shouldn't be surprising to those who have children, that Atlanta Hardwood Flooring is constantly in harm's way from rambunctious babies! The experts at FlooringAtlantaNow are truly masters of the trade, and most recommend using more durable types of wood for high-traffic areas of your home which are prone to scratches or abrasions. Most Atlanta Flooring specialists agree that winter is the best time to do these types of installations and upgrades to your home. Because metro-Atlanta is known for its mild winters, the season offers a perfect climate which tends to be ...

Black flies may have a purpose after all

2012-04-10

Athens, Ga. – Black flies drink blood and spread disease such as river blindness—creating misery with their presence. A University of Georgia study, however, proves that the pesky insects can be useful. Don Champagne, an entomology professor with the UGA College of Agricultural and Environmental Sciences, discovered a way to use the black fly's blood-sucking tactics for medical advancement. The results of his research were published in the journal PLoS One. "In order to feed on blood, these insects have to contend with our natural defense agents against blood loss—like ...

Sexual reproduction brings long-term benefits, study shows

2012-04-10

Courtship rituals can be all-consuming, demanding time and effort – but now scientists have discovered why it might be worth it. Attracting a mate – which can take significant effort, such as in a peacock's show of feathers or the exhaustive rutting of stags – can produce benefits for a species in the long term, a study suggests. Scientists have shown that animals and plants which reproduce sexually are at a considerable advantage to those species – such as some insects and reptiles – that reproduce without a partner. Researchers at the University of Edinburgh studied ...